CCR2b-64I allelic polymorphisms in advanced HIV-infected Koreans accelerate disease progression

AIDS Research and Human Retroviruses

Volumn 23, Issue 6, 2007, Pages 805-811

  Choi, Byeong Sun ^a   Choi, Jang Hoon ^a   Sung, Soon Kim ^a   Kee, Mee Kyung ^a   Lee, Joo Shil ^a  

^a Korea National Institute of Health   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; CD8 ANTIGEN; CHEMOKINE; CHEMOKINE RECEPTOR CCR2; CHEMOKINE RECEPTOR CCR2B; STROMAL CELL DERIVED FACTOR 1; UNCLASSIFIED DRUG;

3' UNTRANSLATED REGION; ADULT; AGED; ALLELISM; ARTICLE; CD4 CD8 RATIO; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; DISEASE COURSE; FEMALE; GENE FREQUENCY; GENE INTERACTION; GENETIC POLYMORPHISM; GENETIC VARIABILITY; GENOTYPE; HETEROZYGOSITY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; KOREA; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RECEPTOR GENE; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SURVIVAL TIME;

ADOLESCENT; ADULT; AGED; CHEMOKINES, CXC; DISEASE PROGRESSION; FEMALE; GENOTYPE; HIV INFECTIONS; HUMANS; KAPLAN-MEIERS ESTIMATE; KOREA; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; PROPORTIONAL HAZARDS MODELS; RECEPTORS, CHEMOKINE;

EID: 34447283047     PISSN: 08892229     EISSN: None     Source Type: Journal    
DOI: 10.1089/aid.2006.0133     Document Type: Article

References (29)

1. Anzala AO, Ball TB, Rostron T, O'Brien SJ, Plummer FA, and Rowland-Jones SL: CCR2-64I allele and genotype association with delayed AIDS progression in African women. University of Nairobi Collaboration for HIV Research. Lancet 1998;351:1632-1633.
2. Brambilla A, Villa C, Rizzardi G, et al.: Shorter survival of SDF1-3′A/3′A homozygotes linked to CD4+ T cell decrease in advanced human immunodeficiency virus type 1 infection. J Infect Dis 2000;182:311-315.
3. Ioannidis JP, Rosenberg PS, Goedert JJ, et al.: Effects of CCR5-Delta32, CCR2-64I, and SDF-1 3′A alleles on HIV-1 disease progression: An international meta-analysis of individual-patient data. Ann Intern Med 2001;135:782-795.
4. Liu H, Hwangbo Y, Holte S, et al.: Analysis of genetic polymorphisms in CCR5, CCR2, stromal cell-derived factor-1, RANTES, and dendritic cell-specific intercellular adhesion molecules-grabbing nonintegrin in seronegative individuals repeatedly exposed to HIV-1. J Infect Dis 2004;190:1055-1058.
5. Smith MW, Dean M, Carrington M, et al.: Contrasting genetic influence of CCR2 and CCR5 variants on HIV-1 infection and disease progression. Hemophilia Growth and Development Study (HGDS), Multicenter AIDS Cohort Study (MACS), Multicenter Hemophilia Cohort Study (MHCS), San Francisco City Cohort (SFCC), ALIVE Study. Science 1997;277:959-965.
6. Magierowska M, Theodorou I, Debre P, et al.: Combined genotypes of CCR5, CCR2, SDF1, and HLA genes can predict the long-term nonprogressor status in human immunodeficiency virus-1-infected individuals. Blood 1999;93:936-941.
7. Winkler C, Modi W, Smith MW, et al.: Genetic restriction of AIDS pathogenesis by an SDF-1 chemokine gene variant. ALIVE Study, Hemophilia Growth and Development Study (HGDS), Multicenter AIDS Cohort Study (MACS), Multicenter Hemophilia Cohort Study (MHCS), San Francisco City Cohort (SFCC). Science 1998;279:389-393.
8. van Rij RP, Broersen S, Goudsmit J, Coutinho RA, Schuitemaker H: The role of a stromal cell-derived factor-1 chemokine gene variant in the clinical course of HIV-1 infection. AIDS 1998;12:F85-90.
9. Vidal F, Peraire J, Domingo P, et al.: Lack of association of SDF-1 3′A variant allele with long-term nonprogressive HIV-1 infection is extended beyond 16 years. J Acquir Immune Defic Syndr 2005;40:276-279.
10. Daar ES, Lynn HS, Donfield SM, et al.: Stromal cell-derived factor-1 genotype, coreceptor tropism, and HIV type 1 disease progression. J Infect Dis 2005;192:1597-1605.
11. Apostolakis S, Baritaki S, Krambovitis E, and Spandidos DA: Distribution of HIV/AIDS protective SDF1, CCR5 and CCR2 gene variants within Cretan population. J Clin Virol 2005;34:310-314.
12. Choi B, Cha S, Kim S, Park Y, and Jooshil L: High frequencies of the CCR2b-64I and SDF1-3′A mutations in Koreans may affect the HIV disease progression. Immune Network 2002;2:86-90.
13. Alkhatib G, Cornbadiere C, Broder CC, et al.: CC CKR5: A RANTES, MIP-1alpha, MIP-1beta receptor as a fusion cofactor for macrophage-tropic HIV-1. Science 1996;272:1955-1958.
14. Choe H, Farzan M, Sun Y, et al.: The beta-chemokine receptors CCR3 and CCR5 facilitate infection by primary HIV-1 isolates. Cell 1996;85:1135-1148.
15. Deng H, Liu R, Ellmeier W, et al.: Identification of a major co-receptor for primary isolates of HIV-1. Nature 1996;381:661-666.
16. Dragic T, Litwin V, Allaway GP, et al.: HIV-1 entry into CD4+ cells is mediated by the chemokine receptor CC-CKR-5. Nature 1996;381:667-673.
17. Doranz BJ, Rucker J, Yi Y, et al.: A dual-tropic primary HIV-1 isolate that uses fusin and the beta-chemokine receptors CKR-5, CKR-3, and CKR-2b as fusion cofactors. Cell 1996;85:1149-1158.
18. Mazzucchelli R, Corvasce S, Violin M, et al.: Role of CCR5, CCR2 and SDF-1 gene polymorphisms in a population of HIV-1 infected individuals. J Biol Regul Homeost Agents 2001;15:265-271.
19. Williamson C, Loubser SA, Brice B, et al.: Allelic frequencies of host genetic variants influencing susceptibility to HIV-1 infection and disease in South African populations. AIDS 2000;14:449-451.
20. Combadiere C, Ahuja SK, Van Damme J, Tiffany HL, Gao JL, and Murphy PM: Monocyte chemoattractant protein-3 is a functional ligand for CC chemokine receptors 1 and 2B. J Biol Chem 1995;270:29671-29675.
21. Charo IF, Myers SJ, Herman A, Franci C, Connolly AJ, and Coughlin SR: Molecular cloning and functional expression of two monocyte chemoattractant protein 1 receptors reveals alternative splicing of the carboxyl-terminal tails. Proc Natl Acad Sci USA 1994;91:2752-2756.
22. Martin MP, Dean M, Smith MW, et al.: Genetic acceleration of AIDS progression by a promoter variant of CCR5. Science 1998;282:1907-1911.
23. Meyer L, Magierowska M, Hubert JB, et al.: CC-chemokine receptor variants, SDF-1 polymorphism, and disease progression in 720 HIV-infected patients. SEROCO Cohort. Amsterdam Cohort Studies on AIDS. AIDS 1999;13:624-626.
24. Mulherin SA, O'Brien TR, Ioannidis JP, et al.: Effects of CCR5-delta32 and CCR2-64I alleles on HIV-1 disease progression: The protection varies with duration of infection. AIDS 2003;17:377-387.
25. Shankarappa R, Margolick JB, Gange SJ, et al.: Consistent viral evolutionary changes associated with the progression of human immunodeficiency virus type 1 infection. J Virol 1999;73:10489-10502.
26. van Rij RP, de Roda Husman AM, Brouwer M, et al.: Role of CCR2 genotype in the clinical course of syncytium-inducing (SI) or non-SI human immunodeficiency virus type 1 infection and in the time to conversion to SI virus variants. J Infect Dis 1998;178:1806-1811.
27. Vicenzi E, Ghezzi S, Brambilla A, et al.: CCR2-64I polymorphism, syncytium-inducing human immunodeficiency virus strains, and disease progression. J Infect Dis 2000;182:1579-1580.
28. Soriano A, Martinez C, Garcia F, et al.: Plasma stromal cell-derived factor (SDF)-1 levels, SDF1-3′A genotype, and expression of CXCR4 on T lymphocytes: Their impact on resistance to human immunodeficiency virus type 1 infection and its progression. J Infect Dis 2002;186:922-931.
29. Tresoldi E, Romiti ML, Boniotto M, et al.: Prognostic value of the stromal cell-derived factor 1 3′A mutation in pediatric human immunodeficiency virus type 1 infection. J Infect Dis 2002;185:696-700.